We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Advertisement

Calixar and VirPath Develop an Innovative Manufacturing Process

News   Sep 25, 2014

 
Calixar and VirPath Develop an Innovative Manufacturing Process
 
 
Advertisement
 

RELATED ARTICLES

Data Shows Pfizer-BioNTech COVID-19 Vaccine Provides Protection From First Dose

News

An independent analysis conducted by Public Health England (PHE) in the UK demonstrates that the Pfizer-BioNTech COVID-19 vaccine BNT162b2 provides protection against infection and asymptomatic disease after the first dose.

READ MORE

First-of-Its-Kind Coronavirus Human Challenge Study Approved in UK

News

Backed by a £33.6 million UK government investment, the first-of-its-kind study for this virus will involve establishing the smallest amount of virus needed to cause infection, which will give doctors greater understanding of COVID-19 and help support the pandemic response by aiding vaccine and treatment development.

READ MORE

Pfizer COVID-19 Vaccine Provokes Immune Response in Those Previously Infected

News

Researchers from Bar-Ilan University and Ziv Medical Center now report preliminary evidence that people previously infected with the virus responded very strongly to one dose of the Pfizer vaccine, regardless of when they were infected and whether or not they had detectable antibodies against COVID-19 prior to receiving the vaccine.

READ MORE

 

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE